期刊文献+

50例半肝切除治疗肝门部胆管癌的疗效观察 被引量:3

Research in the treatment of hilar cholangiocarcinoma with hemihepatectomy in 50 cases
暂未订购
导出
摘要 目的总结不同手术方式对肝门部胆管癌患者治疗的临床及随访结果,探讨肝门部胆管癌临床治疗中的关键技术及相关预后。方法对50例肝门部胆管癌患者采用不同的手术方式,其中31例患者采用胆道联合局部肝切除术(对照组),19例患者采用半肝切除(观察组),对两组患者根治性切除率和生存率进行比较。结果两组患者根治性切除率分别为35.48%(11/31)和68.42%(13/19),差异有统计学意义(P=0.014),观察组1、3、5年生存率分别为85.4%,58.6%,32.2%;对照组分别为86.1%,65.2%,20.0%,差异有统计学意义(P=0.03)。结论根治性切除是患者获得治愈和长期生存最重要的措施,手术技巧的改进和经验的积累,联合半肝切除可以使肝门部胆管癌得切除率及根治率得到大幅度的提高,改善了肝门部胆管癌的预后。 Objeetive To compare the clinical and follow-up results of different ways of operation for the treatment of patients with hilar cholangiocarcinoma,and to explore its e key technology and related prognosis. Methotls 31 out of 50 patients with biliary and partial liver resection(control group), 19 patients with hemihepatectomy (observation group). Radical resection rate and surviv- al rate were compared in the two groups. Results radical resection rate control group and observation group was 35.48% (11/31) and 68.42 % (13/19), the difference was statistically significant(P= 0. 014) ;the difference of 1,3,5 year survival rates between the two groups were statistically significant (P = 0.03 ), observation group = 85.4 %58. 6 %, 32.2 %, control group : 86.1 %, 65.2 %, 20.0%. Conclusion Radical resection is still the most important measures the patients for cure and long-term survival, radical re- section rate,survival rate,and prognosis could be improved greatly by improving operation skills and experience accumulation,com- bined with hepatectomy.
出处 《重庆医学》 CAS CSCD 北大核心 2013年第31期3773-3775,共3页 Chongqing medicine
关键词 胆管肿瘤 肝门 外科手术 疗效 cholangiocarcinoma, liver door surgery curative effect
  • 相关文献

参考文献13

  • 1陈孝平,黄志勇,张志伟,陈义发,张必翔,江斌,李恩山.小范围肝切除治疗Bismuth-CorletteⅢ型肝门部胆管癌[J].中华外科杂志,2009,47(15):1148-1150. 被引量:28
  • 2董家鸿,项灿宏,孟翔飞.肝门部胆管癌外科治疗中的争议[J].中华消化外科杂志,2010,9(3):165-167. 被引量:13
  • 3孙备,王拥卫,姜洪池.肝门部胆管癌的外科治疗进展[J].中华消化外科杂志,2010,9(3):237-240. 被引量:12
  • 4Aljiffry M, Abdulelah A,Walsh M, et al. Evidence-basedapproach to cholangiocarcinoma : a systematic review ofthe current literature[J]. J Am Coll Surg,2009 ,208( 13):1341-1347.
  • 5Edge SB,Compton CC. The American joint committee oncancer:the 7th edition of the AJCC cancer staging manualand the future of TNM[J]. Ann Surg oncol,2010 ,17(6):1471-1474.
  • 6Benson AR, Abrams 1「A,Ben-Josef E, et al. NCCN clini-cal practice guidelines in oncology: hepatobiliary cancers[j], J Natl Compr Cane Netw,2009 ,7(4) : 350-391.
  • 7Capussotti L,Vigano L,Ferrero A,et al. Local surgicalresection of hilar cholangiocarcinoma : Is there still a place[J] HPB,2008,10(3):174-178.
  • 8Bimurh H, Nakache R, Diamond T. Management strate-gies in resection for hilar cholangiocarcinoma [ J AnnSurg,2007,215(l):31-38.
  • 9Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node me-tastasis from hilar cholangiocarcinoma : audit of 110 pa-tients who underwent regional and paraaortic node dissec-tion[J]. Ann Surg,2001,233(3) :385-392.
  • 10Nuzzo G, Giuliante F,Ardito F,et al. Improvement inperioperative and long-term outcome after surgical treat-ment of hilar cholangiocarcinoma : results of an Italianmulticenter analysis of 440 patients[J]. Arch Surg,2012,147(1)-26-34.

二级参考文献63

  • 1黄志强.肝门部胆管癌外科治疗——现状与思考[J].消化外科,2005,4(5):305-306. 被引量:22
  • 2张斌,吴志勇.肝门部胆管癌的术前胆道引流[J].消化外科,2006,5(6):471-474. 被引量:8
  • 3曾永毅,郑树国,董家鸿.肝门部胆管癌根治性切除术中肝动脉切除重建[J].消化外科,2006,5(6):475-478. 被引量:15
  • 4项灿宏,姚力,李启东,王文跃,刘霞,王泰龄,王成钢.经皮经肝门静脉栓塞术在肝门部胆管癌手术中的应用[J].中国微创外科杂志,2007,7(1):50-53. 被引量:14
  • 5Kondo S,Hirano S,Ambo Y,et al.Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins.Ann Surg,2004,240:95-101.
  • 6Witzigmann H,Berr F,Ringel U,et al.Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma.Ann Surg,2006,244:230-239.
  • 7Belghiti J,Ogata S.Preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma.HPB,2005,7:252-253.
  • 8Parikh AA,Abdalla EK,Vauthey J.Operative considerations in resection of hilar colangiocarcinoma.HPB,2005,7:254-258.
  • 9Nishio H,Nagino M,Nimura Y.Surgical management of hilar cholangiocarcinoma:the Nagoya experience.HPB,2005,7:259-262.
  • 10Yokoyama Y,Nagino M,Nishio H,et al.Recent advances in the treatment of hilar cholangiocarcinoma:portal vein embolization.J Hepatobiliary Pancreat Surg,2007,14:447-454.

共引文献71

同被引文献30

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部